Soft tissue sarcoma in adults.
Over the past year, improved delineation of prognostic factors and other aspects of staging of localized sarcomas have been reported. Although little progress has been made in terms of improvement in adjuvant therapy, new efforts to enhance therapy for advanced disease, particularly through use of dose-intensive chemotherapy regimens with colony-stimulating factor support, have resulted in improved response rates and may herald the development of new chemotherapy regimens, which may be employed in future randomized studies in the early disease setting.
Mertens
W C
WC
Department of Medical Oncology, London Regional Cancer Centre, Ontario, Canada.
Bramwell
V H
VH
D000328:Adult; D006801:Humans; D011379:Prognosis; D012509:Sarcoma / Q000453:epidemiology / Q000235:genetics / Q000628:therapy*; D012983:Soft Tissue Neoplasms / Q000453:epidemiology / Q000235:genetics / Q000628:therapy*